PEOPLE - Changes at Cook (US):
This article was originally published in Clinica
Cook (Bloomington, Indiana) has promoted Mike Hughes to director of corporate accounts. Mr Hughes, who has eleven years of service with the company, most recently served as general manager of national accounts. The company has also appointed Jim Gardner as medical science officer. In the newly created position, Mr Gardner will be responsible for ensuring regulatory compliance, evaluating protocols for future clinical trials and submitting approvals to the US FDA.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.